ArticleOPEN ACCESS

Bendamustine plus rituximab in newly-diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO)

British Journal of Haematology
DOI: 10.1111/bjh.15718
60Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

This article is free to access.

Author supplied keywords

Cite

CITATION STYLE

APA

Laribi, K., Poulain, S., Willems, L., Merabet, F., Le Calloch, R., Eveillard, J. R., … Leblond, V. (2019, July 1). Bendamustine plus rituximab in newly-diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO). British Journal of Haematology. Blackwell Publishing Ltd. https://doi.org/10.1111/bjh.15718

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free